TruAlt Bioenergy operates as a dedicated biofuels platform across ethanol, compressed biogas (CBG), sustainable aviation fuel (SAF), and fuel retail. The core economics currently rely on its 55 to 60 crore litre annual ethanol production capacity, where it claims to be the largest private player in India by installed capacity. The business sits in a highly regulated value chain, selling primarily to government oil marketing companies (OMCs) and private retailers. Ethanol margins are structurally constrained by feedstock costs and government pricing, with Q1 FY27 EBITDA at 23.5% and a targeted peak of 20 to 22%. The true economic quality of the business emerges in the CBG vertical, which generated a 60.75% EBITDA margin and a 42.13% net profit margin in FY26. This margin dichotomy reveals a business where the baseline ethanol cash flows fund expansion into structurally higher-margin energy verticals.
The durability of these economics rests on specific feedstock integration and capital partnerships rather than broad market dominance. For ethanol, the barrier is operational flexibility, with three of five plants converted to dual-feed capability to consume the cheapest available raw material across maize, broken rice, and syrup. This allows year-long plant runs of 200 to 230 days on grains and 100 days on syrup, mitigating seasonal supply shocks. For CBG, the barrier is site-specific raw material security, requiring 3x the press mud availability within a 20 to 30 km radius of plant locations to ensure uninterrupted operations. The capital intensity of scaling these verticals is mitigated through joint ventures, with Sumitomo holding a 49% stake in the CBG gas subsidiary and GAIL holding a 49% stake in the Leafiniti Bioenergy subsidiary, shifting a portion of the expansion risk to global partners.
Over the next 18 to 24 months, the business will undergo a structural capacity inflection, scaling CBG production from 10 tons per day (TPD) to 162 TPD by the end of FY27. This expansion involves commissioning three 20 TPD plants with Sumitomo by Q3 and Q4 FY27, and six 10 to 12 TPD plants with GAIL by Q4 FY27, funded via a 70:30 debt-to-equity mix with NABARD debt at 8.65%. Concurrently, ethanol sales are targeted to scale from 36 to 37 crore litres in FY26 to 44 crore litres in FY27 based on current orders, with a bonus target of 55 crore litres if a court-mandated 15 crore litre allocation is implemented. By FY28, the company expects the INR2,000 crore SAF plant in Andhra Pradesh to begin generating revenue, targeting 10 crore litres of annual production at a 24 to 25% EBITDA margin, fundamentally shifting the revenue mix away from pure ethanol dependency.
Management's execution trajectory shows a mixed record of delivering on volume targets while exceeding margin expectations. In November 2025, management guided 41 crore litres of ethanol sales for FY26, but subsequently revised this down to 36 to 37 crore litres in February 2026, citing farmer protests and delayed plant integration. While they achieved the reduced volume target, the original guidance was missed by 10 to 12%. Conversely, CBG margins consistently exceeded guidance, delivering a 63.34% EBITDA margin for the nine months ended December 2025 against a guided 45%. Capex timelines for CBG plants experienced a 3 to 4 month slippage, with construction beginning in December 2025 and completion pushed to July 2026. The balance sheet carries approximately INR180 crore in annual finance costs, but pledged shares with SBI and IREDA are expected to be released in Q2 FY27, and the company holds over INR1,100 crores of capital on hand to secure feedstock.
The quantified earnings path requires ethanol capacity utilization to increase by 20 to 25% from the current 60% in coming quarters, pushing the asset turnover ratio from 1x to a targeted 1.8x to 2x. For this trajectory to hold, the 15 crore litre court-ordered ethanol allocation must be implemented by H1 FY27, and the nine new CBG plants must commission on schedule by Q4 FY27 to contribute incremental revenues at 40 to 50% PAT margins. The single most important watchpoint is the resolution of the Supreme Court LTOA case, which is delaying the 15 crore litre ethanol allocation and keeping INR500 crores of ethanol inventory unsold. If this allocation is delayed further, the earnings delta from the ethanol vertical collapses, leaving the company reliant on the slower-ramping CBG vertical to cover its INR180 crore annual finance costs.
companyname: TruAlt Bioenergy Limited ticker: TRUALT sector: Bioenergy / Renewable Fuels TruAlt Bioenergy Limited (formerly TruAlt Energy Limited, incorporated 2021) is India's only dedicated listed bioenergy company and one of the country's largest ethanol producers by installed capacity. The company runs four business verticals: first-generation (1G) ethanol, compressed biogas (CBG), sustainable aviation fuel (SAF), and fuel retail. As of March 31, 2026, it had 952 employees, with plants acro...
Read the full report →capex, regulatory approval, new product segment, acquisition inorganic
CBG production capacity to increase from 10 tons/day to 162 tons/day by FY27 end driven by commissioning of nine new plants (three with Sumitomo and six with GAIL)
Guidance upgradedmixed
Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for TruAlt Bioenergy Ltd and 4,900+ companies.
5-day free pass. No card required.